RADVAX: Nivolumab / ipilimumab with SBRT for metastatic renal cell carcinoma

Integrative molecular characterisation of S/R RCC to reveal determinants of poor prognosis and response to ICIs

Cytoreductive nephrectomy for mRCC treated with immune checkpoint inhibitors or targeted therapy

NEO-BLADE: Nintedanib or placebo with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer

NIVOREN: Nivolumab in a 'real world setting' for metastatic clear-cell renal cell carcinoma

Sitravatinib and nivolumab combo for advanced clear cell renal cell cancer

BLASST-1: Combining nivolumab, gemcitabine and cisplatin for the neoadjuvant treatment of muscle invasive bladder cancer

ASCO GU 2020: Updates in renal cancer

Treatment of late stage adenocarcinoma

Diagnosis and staging of oral cancer

Management of advanced oral cancer

Advanced stomach and colorectal cancers